Literature DB >> 10515228

Upregulation of vascular endothelial growth factor is associated with radiation-induced blood-spinal cord barrier breakdown.

M N Tsao1, Y Q Li, G Lu, Y Xu, C S Wong.   

Abstract

The pathogenesis of radiation-induced injury to the central nervous system (CNS) remains unclear. Dysfunction of the blood-brain barrier (BBB) is associated with radiation-induced white matter lesions. The aim of this study was to determine if vascular endothelial growth factor (VEGF) is implicated in radiation-induced BBB disruption. Adult rats were irradiated with a single dose of 8 or 22 Gy to the spinal cord from C2 to T2. At various times up to 20 weeks following irradiation, blood-spinal cord barrier (BSCB) permeability was assessed using immunohistochemistry with anti-albumin antibody. Cell proliferation was assessed using bromodeoxyuridine (BrdU), and endothelial cell identity was assessed morphologically and using immunostaining for factor VIII-related antigen. Expression of VEGF protein and message was assessed using immunohistochemistry and in situ hybridization respectively. In the unirradiated rat spinal cord, there was no evidence of albumin immunoreactivity and little evidence of VEGF expression. After a dose of 22 Gy, focal albumin staining in white matter was observed at 16 weeks. Diffuse staining was seen at 20 weeks and was associated with necrosis and demyelination in white matter. This was associated with a significant increase in white matter glial cells that showed immunoreactivity and in situ hybridization signal for VEGE VEGF expressing cells showed dual immunoreactivity for glial fibrillary acidic protein. No increase in VEGF positive cells was observed in gray matter after 22 Gy. After a dose of 8 Gy, there was no increase in VEGF expression or albumin immunostaining in either white or gray matter. Microvessel endothelial cell density showed a trend towards a decrease with time after 22 Gy as compared with 8 Gy or unirradiated controls. BrdU immunostaining provided no evidence for endothelial cell proliferation in control or in the irradiated spinal cord. It is concluded that radiation-induced BSCB dysfunction is associated with upregulation of VEGF in astrocytes without associated endothelial proliferation. The temporal and spatial association of VEGF upregulation with the white matter lesions suggests a role of VEGF in radiation-induced late CNS injury.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10515228     DOI: 10.1097/00005072-199910000-00003

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  32 in total

Review 1.  Organotypic Spinal Cord Culture: a Proper Platform for the Functional Screening.

Authors:  Sareh Pandamooz; Mohammad Nabiuni; Jaleel Miyan; Abolhassan Ahmadiani; Leila Dargahi
Journal:  Mol Neurobiol       Date:  2015-08-27       Impact factor: 5.590

2.  Ranibizumab for the Prevention of Radiation Complications in Patients Treated With Proton Beam Irradiation for Choroidal Melanoma.

Authors:  Ivana K Kim; Anne Marie Lane; Purva Jain; Caroline Awh; Evangelos S Gragoudas
Journal:  Trans Am Ophthalmol Soc       Date:  2016-08

Review 3.  Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy.

Authors:  Erqi L Pollom; Lei Deng; Reetesh K Pai; J Martin Brown; Amato Giaccia; Billy W Loo; David B Shultz; Quynh Thu Le; Albert C Koong; Daniel T Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-07-01       Impact factor: 7.038

4.  An analysis of radiation necrosis of the central nervous system treated with bevacizumab.

Authors:  Karen Tye; Herbert H Engelhard; Konstantin V Slavin; M Kelly Nicholas; Steven J Chmura; Young Kwok; Dominic S Ho; Ralph R Weichselbaum; Matthew Koshy
Journal:  J Neurooncol       Date:  2014-02-07       Impact factor: 4.130

Review 5.  Delayed brain radiation necrosis: pathological review and new molecular targets for treatment.

Authors:  Motomasa Furuse; Naosuke Nonoguchi; Shinji Kawabata; Shin-Ichi Miyatake; Toshihiko Kuroiwa
Journal:  Med Mol Morphol       Date:  2015-12       Impact factor: 2.309

6.  Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.

Authors:  Victor A Levin; Luc Bidaut; Ping Hou; Ashok J Kumar; Jeffrey S Wefel; B Nebiyou Bekele; Jai Grewal; Sujit Prabhu; Monica Loghin; Mark R Gilbert; Edward F Jackson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-01       Impact factor: 7.038

7.  Specificity of vascular endothelial growth factor treatment for radiation necrosis.

Authors:  Carlos J Perez-Torres; Liya Yuan; Robert E Schmidt; Keith M Rich; Robert E Drzymala; Dennis E Hallahan; Joseph J H Ackerman; Joel R Garbow
Journal:  Radiother Oncol       Date:  2015-09-12       Impact factor: 6.280

8.  Pseudoprogression successfully treated with bevacizumab in a child with spinal pilocytic astrocytoma.

Authors:  Kenji Miyata; Toshinori Hori; Yasuto Shimomura; Masahiro Joko; Masakazu Takayasu; Akihisa Okumura
Journal:  Childs Nerv Syst       Date:  2018-05-27       Impact factor: 1.475

Review 9.  Mechanisms of radiation-induced brain toxicity and implications for future clinical trials.

Authors:  Jae Ho Kim; Stephen L Brown; Kenneth A Jenrow; Samuel Ryu
Journal:  J Neurooncol       Date:  2008-01-22       Impact factor: 4.130

10.  Mast Cells Contribute to Radiation-Induced Vascular Hyperpermeability.

Authors:  Kyung Ran Park; Wayne L Monsky; Chang Geol Lee; Chang Ho Song; Dong Heui Kim; Rakesh K Jain; Dai Fukumura
Journal:  Radiat Res       Date:  2016-01-15       Impact factor: 2.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.